CA-AMERICAN-EXPRESS
31.12.2022 14:01:42 CET | Business Wire | Press release
Today American Express (NYSE:AXP) reopened the newly expanded Centurion Lounge at the San Francisco International Airport (SFO). At 16,000 square feet the lounge is now nearly double in size and features more seating, an additional bar with specialty wine flights curated by sommelier and Centurion Lounge Wine Director Anthony Giglio, and a new menu from San Francisco’s Liholiho Yacht Club Executive Chef Ravi Kapur.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221231005003/en/
American Express Opens 16,000 Square Foot Centurion Lounge at San Francisco International Airport (Photo: Business Wire)
“We’re excited to head into the new year with the opening of our Centurion Lounge at San Francisco International Airport,” stated Pablo Rivero, Vice President & General Manager, Global Lounge Experiences. “With exceptional food, wine and art inspired by Northern California, this well-appointed lounge is designed to leave Card Members feeling refreshed and ready for their travels.”
The Centurion Lounge at SFO will now have more space for eligible Card Members to enjoy, including two wine bars and café areas, additional restrooms, private phone rooms, several private workspaces, and more. The lounge is located in Terminal 3 on the mezzanine level.
LOCALLY SOURCED WINE1
The lounge will feature a new bar where guests can enjoy specialty wine flights highlighting four regional wines curated by renowned wine authority Anthony Giglio. The new bar complements the existing wine wall where guests can sample wines from across California. The wine flights will rotate seasonally, starting today with a Sonoma Chardonnay flight and a Napa Valley Cabernet Sauvignon flight:
Sonoma Chardonnay Flight
- Gundlach Bundschu Sonoma Coast Chardonnay 2020
- Head High Sonoma County Chardonnay 2021
- Sonoma Cutrer Les Pierres Sonoma Valley Chardonnay 2019
- Walt Sonoma Coast Chardonnay 2019
Napa Cabernet Sauvignon Flight
- Emblem Napa Valley Cabernet Sauvignon 2019
- Miner Emily's Cuvee Napa Valley Cabernet Sauvignon 2018
- The Critic Napa Valley Cabernet Sauvignon 2019
- Twenty Rows Napa Valley Reserve Cabernet Sauvignon 2020
“As San Francisco is globally known for its world-class wine, the wine menu in the Centurion Lounge at San Francisco International Airport is fully dedicated to highlighting local California grapes,” said Anthony Giglio, sommelier and Centurion Lounge Wine Director. “For our first-ever wine flight experience, I’m thrilled to feature two of America’s most famous and established wine regions - Sonoma and Napa Valley.”
ELEVATED DINING AND DESIGN
The lounge will offer a new seasonal menu that celebrates Bay Area purveyors from Liholiho Yacht Club Executive Chef Ravi Kapur. The Hawaiian-born, James Beard Award-nominated chef will continue to bring his unique flair to the Centurion Lounge at SFO with dishes inspired by his lineage and family memories including, Kochujang marinated chicken thighs, wild rice and coconut soup, and black vinegar and honey glazed baby carrots.
Consumers appreciate premium dining options when traveling through airport lounges. A recent Amex Trendex* survey found that a majority of respondents (64%) said that premium food and beverage offerings are their favorite parts of airport lounges.
The lounge will showcase two custom floor-to-ceiling wallcoverings by abstract artist Tracie Cheng, and new interior design that takes cues from the local vineyards, landscape, and the iconic San Francisco fog to give guests a sense of relaxation.
UNPARALLELED ACCESS
With more lounge options than any other credit card issuer on the market and the only credit card issuer with a proprietary lounge at SFO, the American Express Global Lounge Collection™ is just one of the many ways American Express supports Card Members through their travels. American Express continues to enhance the Centurion Lounge network through new locations and expanding existing lounges. American Express has announced plans to open new lounge locations at the Reagan National Airport (DCA) in Washington, D.C. and Hartsfield-Jackson Atlanta Airport (ATL) in 2023 and 2024 respectively.
*AMEX TRENDEX METHODOLOGY
This Amex Trendex online poll was conducted between November 4th – November 7th, 2022, among a sample of 2000 Adults with an HHI> 70k+ who travel by plane at least once a year. The interviews were conducted online. Results from the full survey have a margin of error of plus or minus 2 percentage points
ABOUT AMERICAN EXPRESS
American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress.
Key links to products, services and corporate sustainability information: personal cards, business cards and services, travel services, gift cards, prepaid cards, merchant services, Accertify, Kabbage, Resy, corporate card, business travel, diversity and inclusion, corporate sustainability and Environmental, Social, and Governance reports.
ABOUT THE CENTURION LOUNGE
The Centurion Lounge is the signature lounge program within the broader American Express Global Lounge Collection, which includes access to American Express Centurion Lounges, international American Express lounges, Delta Sky Club® for Card Members flying on Delta, Priority Pass™ Select Lounges upon enrollment, Airspace Lounges, MAG U.S. Escape Lounges and Plaza Premium Lounges--a total of more than 1,400 lounges across 140 countries and counting.
Eligible Card Members can find a lounge at the Global Lounge Collection website or by using the American Express® App. They can also check into select Centurion Lounges through the mobile check-in tool within the American Express® App.
ABOUT SAN FRANCISCO INTERNATIONAL AIRPORT
SFO is excited to welcome travelers back to the skies with an airport experience featuring seamless access, thoughtful amenities, sustainable design and inspiring artwork and exhibits.
For up-to-the-minute departure and arrival information, airport maps and details on shopping, dining, cultural exhibitions, ground transportation and more, visit www.flysfo.com. Follow us on twitter.com/flysfo and facebook.com/flysfo.
Source: American Express Company
Location: U.S.
1 Must be of legal age to consume alcoholic beverages. Please drink responsibly.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221231005003/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom